Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Carboplatin-paclitaxel is preferred for advanced lung cancer due to its balance of affordability and patient well-being.

Organ transplant recipients have a higher risk of skin cancer over time, atopic dermatitis skin shows unusual bacterial and fungal patterns, a new tool for measuring hidradenitis suppurativa severity was created, and gene expression changes in male baldness suggest new treatments.

Testosterone metabolism in balding scalp cells may not be the main cause of hair loss.

Photodynamic therapy improved skin issues from sorafenib when other treatments failed.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Sintilimab treatment caused hair loss but led to complete tumor remission.

Pulsed electric field treatment may help shrink untreated liver tumors.

Pulsed electric field treatment may help shrink untreated liver tumors.

Transgender men need personalized cancer care and continued testosterone therapy for well-being.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

Diagnosis of adrenal issues in ferrets should use symptoms, ultrasound, and surgery, not ACTH tests.

Corilagin is the main antitumor component in Phyllanthus niruri, effective against cancer cells.

Cetuximab can cause eyelash growth, which is rare but manageable.

Mushroom beta-glucans from Ganoderma lucidum can reduce tumor size and metastasis in cancer.

Sorafenib often causes skin side effects, indicating effective cancer treatment.

Nivolumab can cause hair loss as a rare side effect.

Pazopanib treatment caused rapid hair color loss, possibly indicating its effectiveness.

The document concludes that systemic therapy is becoming more important in treating head and neck cancer, with new treatments showing promise.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

Cetuximab can cause unusual hair growth and hair loss.

Hair analysis can help screen for serious diseases like cancer and osteoporosis.

Short-term side effects of low-dose radioactive iodine therapy are common but temporary.

Rash from EGFRI treatment can indicate both side effects and treatment effectiveness.

Chemotherapy can harm kidneys in breast cancer patients.

Scalp cooling can effectively prevent hair loss during chemotherapy, improving patients' quality of life.

Sreeparna Majumder showed incredible resilience and determination despite battling cancer.